News
WHO Alert: Counterfeit Cancer Medicines Reported in Europe
Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.
[...]January 13, 2025: WHO warns about a fake cancer drug with English packaging
WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.
[...]January 6, 2025: Counterfeit pills are increasingly available globally and their contents are ever more unpredictable
As prescription medications containing fentanyl and other illegal substances are becoming more widely accessible worldwide, a global crackdown on illicit drug precursors is leading cartels to experiment with the contents of their products.
[...]FDA Alert: Recall Issued on “Herbal” Diet Pill Containing Prescription and OTC Drug Ingredients
FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.
[...]December 16, 2024: Black market medicine in Texas and Tennessee
Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.
[...]December 9, 2024: Lawsuit against Snap to proceed
The lawsuit against Snap may proceed and the ADA issued a statement about compounded GLP-1 medicines.
[...]December 2, 2024: Black market HIV drug trafficking costs criminal $31 million in restitution
A California man must pay millions in restitution for selling fake HIV meds. Additional news about Virginia’s state drug importation plans, prosecutions around fentanyl pills, and overseas incidents.
[...]November 25, 2024: A new money laundering case is tied to online pharmacies selling counterfeit pills
A California man allegedly processed payments for foreign online pharmacies selling fentanyl and meth pills.
[...]November 18, 2024: Regulators struggle with GLP-1s in the U.S. and abroad
Novo Nordisk filed five more lawsuits against businesses selling compounded semaglutide. Dr. Tim Mackey spoke about the dangers of the unregulated semaglutide sales online, and South Africa warned residents about counterfeit Ozempic.
[...]FDA Alert: Dietary Supplement Recalled Due to Presence of Sildenafil and Diclofenac
Consumption of products with undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.
[...]